Literature DB >> 20303320

Privileged scaffolds for library design and drug discovery.

Matthew E Welsch1, Scott A Snyder, Brent R Stockwell.   

Abstract

This review explores the concept of using privileged scaffolds to identify biologically active compounds through building chemical libraries. We hope to accomplish three main objectives: to provide one of the most comprehensive listings of privileged scaffolds; to reveal through four selected examples the present state of the art in privileged scaffold library synthesis (in hopes of inspiring new and even more creative approaches); and also to offer some thoughts on how new privileged scaffolds might be identified and exploited. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303320      PMCID: PMC2908274          DOI: 10.1016/j.cbpa.2010.02.018

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  41 in total

Review 1.  Target-oriented and diversity-oriented organic synthesis in drug discovery.

Authors:  S L Schreiber
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

Review 2.  The evolving role of natural products in drug discovery.

Authors:  Frank E Koehn; Guy T Carter
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

Review 3.  Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Authors:  David J Payne; Michael N Gwynn; David J Holmes; David L Pompliano
Journal:  Nat Rev Drug Discov       Date:  2006-12-08       Impact factor: 84.694

4.  Combinatorial library synthesis and biological evaluation of pyrazolo[4,3-e][1,4]diazepine as a potential privileged structure.

Authors:  Ju-Yeon Lee; Yong-Chul Kim
Journal:  ChemMedChem       Date:  2009-05       Impact factor: 3.466

5.  Discovery of indoline-based, natural-product-like compounds as probes of focal adhesion kinase signaling pathways.

Authors:  Rajamohan R Poondra; N Niranjan Kumar; Krikor Bijian; Michael Prakesch; Valérie Campagna-Slater; Ayub Reayi; P Thirupathi Reddy; Asna Choudhry; Michael L Barnes; Donald M Leek; Malgosia Daroszewska; Caroline Lougheed; Bin Xu; Matthieu Schapira; Moulay A Alaoui-Jamali; Prabhat Arya
Journal:  J Comb Chem       Date:  2009-03-09

6.  Natural compounds: leads or ideas? Bioinspired molecules for drug discovery.

Authors:  Terence Beghyn; Rebecca Deprez-Poulain; Nicolas Willand; Benoit Folleas; Benoit Deprez
Journal:  Chem Biol Drug Des       Date:  2008-06-11       Impact factor: 2.817

Review 7.  From nature to drug discovery: the indole scaffold as a 'privileged structure'.

Authors:  Fernando Rodrigues de Sá Alves; Eliezer J Barreiro; Carlos Alberto Manssour Fraga
Journal:  Mini Rev Med Chem       Date:  2009-06       Impact factor: 3.862

8.  The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library.

Authors:  B A Bunin; M J Plunkett; J A Ellman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 9.  2-Arylbenzothiazole as a privileged scaffold in drug discovery.

Authors:  A A Weekes; A D Westwell
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.

Authors:  N S Gray; L Wodicka; A M Thunnissen; T C Norman; S Kwon; F H Espinoza; D O Morgan; G Barnes; S LeClerc; L Meijer; S H Kim; D J Lockhart; P G Schultz
Journal:  Science       Date:  1998-07-24       Impact factor: 47.728

View more
  216 in total

1.  An allenic Pauson-Khand approach to 6,12-guaianolides.

Authors:  Francois Grillet; Chaofeng Huang; Kay M Brummond
Journal:  Org Lett       Date:  2011-11-09       Impact factor: 6.005

2.  Synthesis and diversification of 1,2,3-triazole-fused 1,4-benzodiazepine scaffolds.

Authors:  James R Donald; Stephen F Martin
Journal:  Org Lett       Date:  2011-01-28       Impact factor: 6.005

3.  Facile and unified approach to skeletally diverse, privileged scaffolds.

Authors:  James J Sahn; Justin Y Su; Stephen F Martin
Journal:  Org Lett       Date:  2011-04-22       Impact factor: 6.005

4.  Multicomponent assembly strategies for the synthesis of diverse tetrahydroisoquinoline scaffolds.

Authors:  Brett A Granger; Kyosuke Kaneda; Stephen F Martin
Journal:  Org Lett       Date:  2011-08-11       Impact factor: 6.005

5.  Application of a sequential multicomponent assembly process/huisgen cycloaddition strategy to the preparation of libraries of 1,2,3-triazole-fused 1,4-benzodiazepines.

Authors:  James R Donald; Rebekah R Wood; Stephen F Martin
Journal:  ACS Comb Sci       Date:  2012-02-01       Impact factor: 3.784

6.  Structure-Based Screening of Uncharted Chemical Space for Atypical Adenosine Receptor Agonists.

Authors:  David Rodríguez; Saibal Chakraborty; Eugene Warnick; Steven Crane; Zhan-Guo Gao; Robert O'Connor; Kenneth A Jacobson; Jens Carlsson
Journal:  ACS Chem Biol       Date:  2016-08-22       Impact factor: 5.100

7.  Cyclosulfamide-based derivatives as inhibitors of noroviruses.

Authors:  Dengfeng Dou; Sivakoteswara R Mandadapu; Kevin R Alliston; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Eur J Med Chem       Date:  2011-10-20       Impact factor: 6.514

8.  A simple one-pot 2-step N-1-alkylation of indoles with α-iminoketones toward the expeditious 3-step synthesis of N-1-quinoxaline-indoles.

Authors:  Guillermo Martinez-Ariza; Muhammad Ayaz; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2013-12-04       Impact factor: 2.415

9.  Cycloisomerization of Olefins in Water.

Authors:  Jeishla L M Matos; Samantha A Green; Yuge Chun; Vuong Q Dang; Russell G Dushin; Paul Richardson; Jason S Chen; David W Piotrowski; Brian M Paegel; Ryan A Shenvi
Journal:  Angew Chem Int Ed Engl       Date:  2020-05-28       Impact factor: 15.336

Review 10.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.